Tuesday, May 20, 2025
==NeurAxis (NRXS) : FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea Symptoms
CARMEL, Ind., May 20, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that it has received FDA 510(k) clearance for IB-Stim™ for the treatment of Pediatric Functional Abdominal Pain (FAP) associated with Functional Dyspepsia, and FD related Nausea Symptoms, in patients aged 8 to 21 years. This clearance is the second successful expanded FDA indication for IB-Stim, following its initial approval for Functional Abdominal Pain associated with Irritable Bowel Syndrome (IBS). The new indication represents the first treatment ever cleared or approved by the FDA related to functional dyspepsia. It is expected to nearly double the Company’s total addressable market, reinforcing NeurAxis’ leadership in non-invasive, pediatric-focused neuromodulation.
About NeurAxis, Inc.
NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive adoption of its IB-Stim™ therapy, which is its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim™ is FDA cleared for functional abdominal pain associated with irritable bowel syndrome (IBS) in adolescents 8-21 years old. Additional clinical trials of PENFS in multiple pediatric and adult conditions with large unmet healthcare needs are underway. For more information, please visit http://neuraxis.com.
Saturday, May 17, 2025
US IPO Weekly Recap
Global trading platform eToro Group (ETOR) priced its upsized US IPO above the range to raise $620 million at a $4.9 billion market cap. eToro’s platform aims to combine a social network with the ability to trade and invest, all within a regulated, digital investment platform for financial discourse. As of December 31, 2024, eToro had approximately 3.5 million Funded Accounts across its global footprint of 75 countries. The company’s total commission grew 45% in 2024, and its net contribution grew 41%. However, it is dependent on volatile trading volumes and prices, and is subject to varying regulations, especially within the crypto space. eToro finished the week up 23%.
Singapore-based digital asset-focused financing firm Antalpha Platform Holding (ANTA) priced its US IPO at the top of the range to raise $49 million at a $329 million market cap. Antalpha provides financing, technology, and risk management solutions to the digital asset industry. The company is the primary lending partner for Bitmain and provides supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. Its revenue jumped more than three times in 2024, although it demands on volatile crypto demand and prices. It finished the week down 6%.
Singapore-based oil and gas equipment maker OMS Energy Technologies (OMSE) priced its downsized US IPO at the midpoint to raise $33 million at a $382 million market cap. The company manufactures surface wellhead systems and oil country tubular goods, primarily for onshore and offshore E&P activities. OMS has a 10-year agreement with Saudi Aramco, which accounts for a majority of the company’s revenue. It finished the week down 13%.
Autonomous delivery systems developer Arrive AI (ARAI) completed its direct listing this week. Arrive AI is developing autonomous last mile mailboxes, designed to support deliveries done by robots and drones. Arrive AI is also developing a suite of software and services for its mailboxes, including features for scheduling, space optimization, and notifications. The company is in the development stage, and has generated no revenues to date. Its finished the week down 21%.
Six SPACs listed this week. Churchill Capital X (CCCXU), founded by former Citi executive Michael Klein, raised $360 million. Wen Acquisition (WENNU) raised $261 million to target fintech and blockchain. Cohen & Company-backed Columbus Circle Capital I (CCCMU) raised $220 million. Renatus Tactical Acquisition (RTACU), led by the former CEO of Digital World Acquisition, raised $210 million to target tech. Perimeter Acquisition I (PMTRU) raised $210 million to target defense and national security. Thayer Venture Acquisition II (TVAIU), the second blank check company formed by Thayer Ventures, raised $175 million to target travel and transportation.
Monday, May 12, 2025
Life360 (LIF) reported earnings on Mon 12 May 25 (a/h)
- Sector: Technology
- Industry: Software - Application
- Full Time Employees: 455
- Incorporated in 2007
- Headquartered in San Mateo, California
- https://intl.life360.com
ticker: LIF
** charts after earnings **
ticker: LIF
IPO: June 6, 2024
Life360
(LIF) — a provider of tracking services for family, pets and valuables —
late Monday beat Wall Street's revenue estimate for the first quarter
but came up short on total users. Its full-year sales guidance also was
light. Life360 stock fell in extended trading.
The
San Mateo, Calif.-based company said it earned 5 cents a share on sales
of $103.6 million in the March quarter. In the year-earlier period, it
lost 14 cents a share on sales of $78.2 million. Analysts polled by
FactSet had expected sales of $101.4 million in the first quarter.
Life360
ended the period with 83.7 million global monthly active users, up 26%
year over year. However, analysts were expecting 84.5 million.
The
company also added 137,000 accounts to its subscription offering,
ending the period with 2.4 million Paying Circles worldwide. A Paying
Circle is a group of Life360 members with a paying subscription.
Life360
describes itself as a "family connection and safety company." It sells
Tile-brand tracking devices and subscription services for families to
keep track of loved ones and valuable items like purses, wallets, car
keys and bikes.
Monday, May 5, 2025
Black Rifle Coffee Co. (BRCC) reported earnings on Mon 5 May 25 (a/h)
BRC
Inc. operates as a veteran-controlled, non-alcoholic beverage company
that uniquely blends high-quality coffee production with military and
firearms-themed merchandise.
- Sector: Consumer Defensive
- Industry: Packaged Foods
- Full Time Employees: 551
- Founded in 2014
- HQ in Salt Lake City, Utah
- https://www.blackriflecoffee.com
ticker: BRCC
** charts after earnings **
SALT LAKE CITY--(BUSINESS WIRE)--BRC Inc. (NYSE: BRCC), a Veteran-founded, mission-driven premium beverage company, today announced financial results for the first quarter of fiscal year 2025.
- In Q1 2025, packaged coffee distribution increased by 12.2 percentage points to 50.2% ACV and Ready-to-Drink ("RTD") coffee distribution grew by 5.1 percentage points to 47.9% ACV compared to Q1 2024.
- Wholesale revenue declined 6.0% compared to Q1 2024, primarily due to the net reduction of $8.5 million in prior-year barter transaction revenue.
- Net loss was $7.8 million in Q1 2025, a decrease of $9.7 million compared to net income of $1.9 million in Q1 2024. Adjusted EBITDA was $0.9 million, down $11.6 million from $12.5 million in Q1 2024.
IPOs this week : May 5 - 9, 25 (wk 19)
American Integrity – Tampa, Fla., 6.9 million shares, priced at $15-$17, managed by KBW Piper Sandler. Proposed NYSE symbol AII. Business: Florida-based provider of personal residential property insurance.
OMS Energy Technologies – Singapore, 5.6 million shares, priced at $8-$10, managed by Roth Cap.. Proposed Nasdaq symbol OMSE. Business: Singapore-based manufacturer of surface wellhead systems and oil country tubular goods.
Apimeds Pharmaceuticals – Hopewell, N.J., 3.5 million shares, priced at $4-$5, managed by D. Boral Capital. Proposed NYSE American symbol APUS. Business: Clinical stage biotech developing bee venom-based treatment for inflammation.
Kandal M Venture – Takhmao, Cambodia, 2 million shares, priced at $4-$5, managed by Dominari Sec. Revere Sec.. Proposed Nasdaq symbol FMFC. Business: Cambodia-based contract manufacturer of affordable luxury leather goods.
Friday, May 2, 2025
AirSculpt Technologies (AIRS) reported earnings on Fri 2 May 25 (b/o)
AirSculpt Technologies provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.- Sector: Healthcare
- Industry: Medical Care Facilities
- Full Time Employees: 389
- Founded by Aaron J. Rollins in 2012
- Headquartered in Miami Beach, Florida
- https://airsculpt.com
Ticker: AIRS
** charts after earnings **
First Quarter 2025 Results
- Case volume was 3,076 for the first quarter of 2025, representing a 17.9% decline from the fiscal year 2024 first quarter case volume of 3,746;
- Revenue declined 17.3% to $39.4 million from $47.6 million in the fiscal year 2024 first quarter;
- Net loss for the quarter was $2.8 million compared to net income of $6.0 million in the fiscal year 2024 first quarter; and Adjusted EBITDA was $3.8 million compared to $7.3 million for the fiscal year 2024 first quarter.
2025 Outlook
The Company projects full year 2025 revenue and adjusted EBITDA guidance as follows:
- Revenues of approximately $160 to $170 million
- Adjusted EBITDA of approximately $16 to $18 million